Evaluation of an Innovative Information, Training and Social Support Intervention "INFOSADEM" to Principal Caregivers of Dementia Patients Living at Home (INFOSA-DEM)

July 29, 2019 updated by: Adelaida Zabalegui Yarnoz, Hospital Clinic of Barcelona

Evaluation of an Innovative Information, Training and Social Support Intervention "INFOSADEM" to Principal Caregivers of Dementia Patients Living at Home. Experimental Study

Background: Dementia is an illness that mostly affects people of advanced age and causes disability and dependency. Although the difficulties, a vast number of older people with dementia at our context, are cared for in their own homes by a family member, usually their spouse/partner, son, daughter or companion, but it is well known that this could be one of the main factors of institutionalization. However, home care is an effective option for the health system. This care may be provided over months or years and can have negative effects on the caregivers' health. This article describes the development and implementation of a structured, psychoeducational intervention addressed to informal caregivers of people with dementia cared for at home.

Methods: A quasi-experimental study with repeated observations at 3 and 6 months post-intervention was performed. Intentional sampling and convenience assignment method was used for intervention and control groups. The intervention was structured developed at the beginning of the study, which consists of a multicomponent training, information and emotional support programme of five, 90-minute sessions over one week. The control group received Usual Care. The project was approved by the ethics committee (HCB/2014/0317) and follows the recommendations of the Declaration of Helsinki. Evidence gathered from our research will be published at national and international level.

Discussion: The results of this intervention will support other studies and contribute scientific evidence on the importance of promoting non-pharmacologic interventions in informal caregivers of people with dementia. At the same time, they can be used as the basis for the implementation of psycho educational interventions in home care and in long-term care institutions responsible for monitoring people with dementia; responding to training and information needs, and providing the social support that the caregivers themselves demand.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

  1. Eligibility Criteria People with a diagnose of dementia, living at home and having an informal caregiver.

    Inclusion criteria

    • People with a diagnose of dementia
    • People older than 65 years old
    • Living at home and receiving public formal care* from Primary Health Care centers.
    • Having an informal caregiver** identified being capable of understand healthcare professional advices (this will be measured by healthcare professional criteria).
    • Cognitive level having a MMSE score lower of 24 .
    • Informed consent signed. *We considered public formal care, the health care team working on Primary Care (being home care or primary care) (GPs,Registered Nurse, Social Worker).

      • We considered informal caregiver the person (family or not) who takes care of the PwD and lives together or visit him/her at least three times a week.

    Exclusion criteria

    • People lower than 65 years old
    • People with a psychiatric symptom or Korsakov sindrome
    • People without informal caregiver identified
  2. Outcome measures

    • preparation for care through the Preparedness for Caregiving Scale (PCS)
    • Perceived Competence Scale for Care
    • Inventory Family needs
    • Zarit Burden Scale
    • Katz Index of Independence in Activities of Daily Living
    • positive and negative aspects of care with the Caregiver Reaction assessment (CRA)
    • Perceived Social Support Questionnaire (Duke-UNK )
    • Quality of Life Scale (EQ-5D)
    • General Health Questionnaire (GHQ-12)
    • Resource Utilization Questionnaire for dementia (RUD)
    • Neuropsychiatric Inventory (NPI) .
    • Quality of Life in Alzheimer's Disease (QoL-AD)
    • Charlson Comorbidity Index (CCI)
    • Mini-Mental State Examination (MMSE)
    • Global Deterioration Scale (GDS)

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • People with a diagnose of dementia
  • People older than 65 years old
  • Living at home and receiving public formal care* from Primary Health Care centers.
  • Having an informal caregiver** identified being capable of understand healthcare professional advices (this will be measured by healthcare professional criteria).
  • Cognitive level having a MMSE score lower of 24 .

    • We considered public formal care, the health care team working on Primary Care (being home care or primary care) (GPs, Registered Nurse, Social Worker). **We considered informal caregiver the person (family or not) who takes care of the PwD and lives together or visit him/her at least three times a week.

Exclusion Criteria:

  • People lower than 65 years old
  • People with a psychiatric symptom or Korsakov sindrome
  • People without informal caregiver identified

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention group

The INFOSA-DEM programme consists of five, 90-minute informational/training sessions delivered consecutively over one week. Morning or afternoon groups are offered depending on the caregiver's availability. Programme content was developed for use in small groups of 6-8 caregivers. Topics covered in the sessions include basic concepts in dementia and specific issues such as nutrition, rest, medication, physical and cognitive changes, management of behavioural symptoms, affective problems in the patient and informal caregiver, verbal and non-verbal communication techniques, caregiver self-care and information on available resources and community services.

The sessions are conducted using audio-visual material to facilitate understanding of the content and to encourage active participation among caregivers when talking about their experiences.

Caregivers in the intervention group received the INFOSA-DEM programme, together with usual care provided by the participating centres, while caregivers in the CG received usual care in the centres where the follow-up was carried out.
No Intervention: usual care
Caregivers in the Group control received usual care in the centres where the follow-up was carried out. This consisted of annual or quarterly consultations with a health professional (GP, geriatrician or neurologist) and, depending on the health centre, a nurse and social worker.Currently, there is no homogenous protocol for all care centres for the patient with high levels of cognitive impairment and dependency.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preparedness for Caregiving
Time Frame: 2 years
Preparedness for Caregiving Scale (PCS; 8 items): Assess readiness for tasks and demands of caregiving role. Domains include providing physical care, providing emotional support, setting up in-home support services and deling with the stress of caregiving. Participants are asked to identified how well prepared they feel on a scale from not all prepared (0) to very well prepared (4). Cronbach's Alpha: 0.88-93
2 years
positive and negative aspects of care
Time Frame: 2 years
. Caregiver Reaction Aspects (CRA; 24 items): consists of 24 items in five subscales: self-esteem (range 7-35), lack of family support (range 5-25), financial problems (range 3-15), disrupted schedule (range 5-25) and health problems (range 4-20).
2 years
perceived social support
Time Frame: 2 years
Perceived Social Support Questionnaire (Duke-UNK; 8 items): Instrument to measure the strength of the person's social support network. Cronbach's Alpha: 0.88.
2 years
Level of Quality of life: EQ-5D
Time Frame: 2 years
Quality of Life Scale (EQ-5D): a measure of self-reported quality of life that is applicable to a wide range of health conditions and treatments. It consists of two parts: a descriptive system (Part I) and a visual analogue scale (VAS) (Part II). Cronbach's Alpha: 0.87.
2 years
FAMILY NEEDS
Time Frame: 2 years
Family needs inventory
2 years
level of burden
Time Frame: 2 years
Zarit Burden Scale (ZBS; 22 items): a questionnaire developed to measure subjective burden among caregivers. Cronbach's Alpha: 0.92.
2 years
Neuropsychiatric Inventory (NPI)
Time Frame: 2 years
Assess dementia-related behavioral symptoms. Is composed by 10 sub-domains: delusions, hallucinations, agitation/aggression, dysphoria, anxiety, euphoria, apathy, deshinibition, irritability/liability, and aberrant motor activity. Cronbach's Alpha:0.88
2 years
degree of independence in activities of daily living
Time Frame: 2 years
Katz index of Activity of Daily Living (KATZ; 5 items): to assess an older adult's baseline ability to bathe, dress, use the toilet, transfer, remain continent, and feed her- or himself. It's also used for evaluating changes in response to illness. Cronbach's Alpha: 0.87
2 years
Competence for care
Time Frame: 2 years
The Perceived Competence Scale for Care
2 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
level of cognitive deterioration
Time Frame: 2 years
Global Deterioration Scale (GDS): provides caregivers an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease. It is broken down into 7 different stages. Stages 1-3 are the pre-dementia stages. Stages 4-7 are the dementia stages. Beginning in stage 5, an individual can no longer survive without assistance.
2 years
Comorbidity
Time Frame: 2 years
Charlson Comorbidity Index (CCI): Assess multiple comorbidity. To complete the Index, patients are asked whether they have a history of medical problems in 12 areas. Among patients with chronic medical conditions, the Index categories were predictive of 1-year mortality and health care costs. Cronbach's Alpha: 0.96.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

June 30, 2018

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

July 25, 2019

First Submitted That Met QC Criteria

July 29, 2019

First Posted (Actual)

July 30, 2019

Study Record Updates

Last Update Posted (Actual)

July 30, 2019

Last Update Submitted That Met QC Criteria

July 29, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on INFOSA-DEM

3
Subscribe